However, pemafibrate ameliorated the FIB-4 index in subjects with severe liver dysfunction (2×ULN < ALT) (Table 2), but this improvement was not statistically significant when compared with the control group (Supplementary Fig. 4). Here, GPT is linked to Decreased liver function.